S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Taki Chemical Net Profit Surges 42% on Robust Annual Revenue

Japanese manufacturer Taki Chemical Co. Ltd. reported a significant jump in annual earnings for the fiscal year ended December 31, driven by steady top-line growth and improved operational margins. The company’s net profit climbed to ¥3.28 billion, a sharp increase from the ¥2.30 billion recorded in the previous year.

Taki Chemical Net Profit Surges 42% on Robust Annual Revenue

The Hyogo-based firm saw its total revenue reach ¥41.98 billion, up from ¥38.92 billion in the prior period. This performance reflects a resilient demand environment for the company's chemical products, allowing it to outpace last year's figures across all primary financial metrics. Operating profit for the year rose to ¥3.16 billion, compared to ¥2.67 billion previously.

Growth in Shareholder Value

According to the company’s financial statement, pretax profit reached ¥3.78 billion, benefiting from the broader increase in business activity. The surge in profitability significantly enhanced shareholder returns, with earnings per share (EPS) jumping to ¥389.05 from ¥271.37.

The results, which were prepared in accordance with Japanese accounting standards, underscore a period of disciplined cost management and market expansion for the Tokyo-listed entity. Taki Chemical (4025.TO) continues to consolidate its position within the domestic industrial sector as it navigates shifting economic conditions in Japan.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!